Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-25-105935

Options or other derivatives

  • SVP, CMO acquired 11,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Huebner Dirk SVP, CMO 2025-08-06 Grant or award · Restricted Stock Unit +11,500 11,500 D
Loading xslF345X05/ownership.xml…